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ABSTRACT
A developing oocyte is capable of synthesizing "non-self" proteins
recognized as foreign by the maternal immune system. Since the oocyte
may be perceived as foreign it must be protected from interaction with the
immune system in order for it to mature to the point of ovulation. Oocytes
that begin development but do not mature to the point of ovulation become
atretic and are destroyed and phagocytized by the maternal system. This
study proposes that the zona pellucida of the ovarian follicle is the barrier
between the immune system and the oocyte. The suggestion is made that
the oocyte may play a role in blocking the immune system during its
maturation, and follicles in which the oocyte is incapable of providing for
its own protection become atretic.
Indirect immunolabelling techniques employing both peroxidase and
fluorochrome-conjugated antibodies were used to assess the presence of
immunoglobulin G, female protein, and albumin in the ovary of the golden
hamster Mesocricetus auratus. This experimental technique indicates that
immunoglobulin G, female protein, and albumin are found localized in the
zona pellucida and liquor folliculi of ovarian follicles.
Intravenous

injection

of

fluorescein-conjugated

hamster

im

munoglobulin G demonstrates the ability of the zona pellucida to limit
access of serum immunoglobulin G to the oocyte.

The labelled im

munoglobulin G circulates rapidly through the animal and does not appear
to be impeded in its access to the follicle. It accumulates rapidly in the

Xll

liquor folliculi and zona pellucida yet never appears within the perivitelline
space.
The results of this study suggest that the zona pellucida is
responsible for separating the developing oocyte from the maternal immune
system, thus forming a "blood-oocyte" barrier to immunoglobulins.
Further speculation is made that the oocyte plays a role in its own
protection by production of factors capable of blocking complement
fixation.

If incapable of providing for its own protection, the oocyte is

acted upon by the maternal immune system. The zona pellucida and liquor
folliculi aid the immune system by providing an area for local storage of
proteins necessary to accomplish complement fixation and subsequent
follicular atresia.

xm

INTRODUCTION

The gonads of all animals are complex organs which are not only
subjected to hormonal regulation, but are also involved in the process of
reproduction by their production of gametes and hormones.
In the male, the testis is the site of production of spermatozoa. This
process is termed spermatogenesis. Spermatogenesis is a complex process
which can be subdivided into four separate stages. The first and second
stages involve cell division. The first stage utilizes mitosis to maintain a
population of undifferentiated stem cells called spermatogonia. This step is
termed spermatocytogenesis. The next stage, called meiosis, involves the
ultimate production of a haploid cell, called the spermatid.

These cells

subsequently differentiate into spermatozoa through spermiogenesis.
Meiosis involves two successive nuclear divisions with one division of
chromosomes.

Spermatogenesis results in the formation of 8 haploid

spermatozoa from one diploid cell, the type B spermatogonia. Briefly, the
process

of

spermatogenesis

is

as

follows:

preleptotene

primary

spermatocytes undergo DNA synthesis and therefore contain 4n DNA, and
2n chromosome number. These cells then enter the prophase of meiosis I.
During

this

extended

prophase

there

is pairing

of homologous

chromosomes, after which there is an interchange of chromatid segments
between the homologous pairs. This interchange is termed crossing-over
and ensures genetic diversity (Sadler, 1985; Dym, 1983). Meiosis I is also
1

2

termed the reductional division since the resultant cells, the secondary
spermatocytes,

have

2n

DNA

and

In

chromosome

number.

Secondary spermatocytes then undergo meiosis II to form spermatids.
Spermatids contain In DNA and In chromosome number, and are referred
to as haploid cells.
A haploid cell is no longer recognized by the body as being "self",
due to the synthesis of proteins that are encoded by DNA of chromosomes
formed through crossing-over. Cell surface antigens specific to adluminal
spermatocytes have been identified (Millette and Bellve, 1977; O'Rand and
Romrell, 1977). The antigens appear during the pachytene stage of the
first meiotic prophase, and are expressed by all germ cells at subsequent
stages of division.

This indicates that pachytene primary spermatocytes

are capable of extensive gene transcription and translation (Millette and
Bellve, 1977).

If spermatids produce antigenic proteins the interaction

between these proteins and circulating immunocytes may induce the
formation of antibodies that could lead to autoimmune phenomena.

A

protective mechanism must exist which limits the interaction of the proteins
of the germ cell coat and the blood circulatory system. The morphological
basis of such a mechanism is found at the level of the Sertoli cell and is
referred to as the blood-testis barrier.

As the spermatocyte undergoes

meiosis I it is isolated by adjacent Sertoli cells, which send out cellular
processes beneath the spermatocyte and connect to each other through tight
junctions (Dym, 1973). In fact, spermatocytes are protected by the bloodtestis barrier before they become true haploid cells. This subdivides the
seminiferous tubule epithelium into two compartments, the adluminal
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compartment which lies on the lumen side of the tight junctions, and the
basal compartment which lies at the basal end of the Sertoli cell. Thus the
basal compartment contains spermatogonia and preleptotene primary
spermatocytes and the adluminal compartment contains the more advanced
stages of germ cell differentiation (Dym, 1973). It is clear from the above
that this barrier enables the Sertoli cells to maintain a microenvironment in
the adluminal compartment which is favorable for germ cell differentiation.
The ovary is the female homologue of the testis and as such should
be expected to have similar structures and functions.

As spermatogonia

are the germ cell line in the testis, oogonia are the germ cells of the ovary.
Whereas the spermatogonia are constantly renewed in the testis, oogonia
cease replication during fetal development. Oogonia give rise to primary
oocytes which enter meiosis I during fetal life and proceed to the diplotene
stage of prophase at which point their maturation is arrested, that is the cell
enters a resting stage. This event occurs before, or shortly after birth and
lasts until division is resumed shortly before ovulation. It should be noted
that the term "resting" refers only to the meiotic inactivity, since arrested
oocytes continue to synthesize RNA (Zamboni, 1971).

It is during

transcription and subsequent translation that unique proteins may form as a
result of crossing-over and nondisjunction.
The majority of primary oocytes remain dormant in the ovary until
the animal reaches puberty at which time an oocyte may resume meiosis.
Meiosis I is not completed until just prior to ovulation.

The resultant

daughter cells are not equal in terms of cytoplasmic distribution.

One

daughter cell, the secondary oocyte, receives the vast majority of the
cytoplasm, the other, called the first polar body, receives only a scant
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amount of cytoplasm. Following ovulation the secondary oocyte proceeds
to metaphase II, at which point further maturation ceases.

The second

meiotic division is completed only if the secondary oocyte is penetrated by
a spermatozoan. (For a review of oogenesis see Moore, 1988).
It should be reiterated that, unlike the spermatozoa, at no time
during its ovarian life is the oocyte considered a haploid cell.

The

necessity of a blood-follicle barrier (Shalgi et al., 1973) or a blood-oocyte
barrier would seem to be in question based upon the above description.
However, during the growth phase of oogenesis the oocytes synthesize the
majority of the components that they bring to the event of fertilization.
Proteins that are known to be synthesized in the growing oocyte include
tubulin (Schultz et al. 1979), lactate dehydrogenase (Brinster, 1965;
Mangia et al., 1976), actin and intermediate filament proteins (Kaplan et
al., 1982), ribosomal proteins (LaMarca and Wassarman, 1979), and the
proteins of the zona pellucida (Bleil and Wassarman, 1980a; Shimizu et
al., 1983). It has been documented that the amount of protein synthesized
by the oocyte when it enters its growth phase is about 38-fold that of a
resting oocyte (Schultz et al., 1979).

If the DNA of the oocyte has

changed, due to crossing-over, then proteins may be produced that will be
recognized as foreign by the host (maternal) system. As with the testis,
interaction of these proteins with the maternal blood may result in the
production of antibodies that could lead to autoimmune phenomena.
The zona pellucida (ZP) is an amorphous glycoprotein coat which is
formed during the development of the oocyte, surrounds the oocyte and
later the blastocyst, and remains intact until implantation (Dunbar, 1983a).
It first appears at the primary unilaminar follicle stage and is considered to
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be fully formed by the primary multilaminar follicle stage. Because the
molecules of the ZP are produced and secreted during the early stages of
oocyte growth and development, they provide excellent markers for this
dynamic process (Oakberg and Tyrell, 1975; Wolgemuth et al., 1984;
Philpott et al., 1987).
The zona pellucida is first seen at the light microscopic level at the
time when the cells surrounding the primary oocyte change from a rather
flat, squamous cell type to a single layer of cuboidal cells (Died, 1989).
The ZP does not form as a complete and continuous extracellular
membrane around the entire circumference of the oocyte but rather as
discontinuous portions which fuse only secondarily to constitute a complete
encasement (Died, 1989).

The ZP is first recognized as amorphous

material lying between the pocket-shaped protrusions of microvilli of the
oocyte membrane and follicular cells.

Initially it is found only very

sparsely distributed in the peri vitelline space. The primary appearance of
ZP material coincides with an increased number of microvilli of the oocyte
and cell protrusions of granulosa cells.

The microvilli extend into the

substance of the ZP and tend to be more numerous than the protrusions of
the adjacent follicle cells. Whereas the plasma membrane of the resting
oocyte shows only a few short microvilli, they become progressively more
numerous and uniformly distributed over the surface of the oocyte
concomitant with the formation of the ZP. Morphologically the maturation
of ZP begins when amorphous granules appear between the oocyte and
hypertrophied follicular cells.

Greve and Wassarman (1985) identified

these glycoprotein granules as zona protein one (ZP1) which has crosslinking properties with individual filaments within the ZP of the mouse.
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The ZP consists of randomly arranged, fibrillogranular materials that give
rise to its amorphous appearance observed in scanning electron
micrographs (Phillips and Shalgi, 1980) and in transmission electron
micrographs (Wassarman and Josefowicz, 1978; Died and Czuppon,
1984). There are fine fibrillogranular connections within the developing
ZP matrix which seem to serve as filament branch points. Perhaps these
fine granular particles are involved in the branching of ZP filaments. A
greater degree of polymerization occurs with ZP growth and the formation
of a glycoprotein network takes place. Ultimately the density of the mature
ZP fibrils increases.

There is, however, a difference in density in the

mature ZP between the inside (facing the oocyte) and the outside (facing
the follicular cells): the fibrils being more densely packed inside than
outside (Dietl and Czuppon, 1984). Further studies have demonstrated that
the ZP of some species appear to contain multiple layers (Hope, 1965;
Wolgemuth et al., 1984).
The origin of the ZP has been the subject of some debate, with some
authors implicating the granulosa cells as the source (Guraya, 1974) while
others choose the oocyte as the source (Tesoriero, 1977; Haddad and
Nagai, 1977; and Bleil and Wassarman, 1980b). Some consider the ZP to
be the product of both the granulosa cells and the oocyte (Chiquoine, 1960;
Hertig and Adams, 1967).
Indirect evidence exists that granulosa cells produce the ZP matrix.
When rabbits are immunized with porcine ZP proteins, the oocytes are
destroyed at the stage at which they begin to initiate formation of the ZP
matrix (Skinner et al. 1984).

Even though there are no remnants of

oocytes, there are distinct matrices which stain identical to ZP surrounded
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by "granulosa" cells.

These matrices are easily distinguished from the

collapsed remnants of ZP from atretic follicles which do not contain
granulosa cells within the center of the collapsed ZP. It therefore appears
from these studies that at least some ZP proteins are produced in the
absence of the oocyte in vivo (Dunbar et al., 1989). Additional evidence
for the synthesis of ZP glycoproteins by granulosa cells is provided by
immunocytochemical localization of ZP glycoproteins in the follicle of the
rabbit (Wolgemuth et al., 1984).
On the other hand, the oocyte appears to be the primary producer of
the ZP. Bousquet et al. (1981) found that a ZP antigen originating from
the oocyte begins to be produced at the stage of the primary follicle.
Studies of the molecular details of the genes that code for the mouse ZP
proteins show that these proteins are synthesized only by the oocyte
genome (Chamberlin et al., 1989). Further studies (Died, 1989) indicate
that in mouse zona protein three (ZP3) expression appears to be oocyte
specific and limited to the growth phase of oogenesis. Fully grown oocytes
do not appear to make ZP proteins (Bleil and Wasserman, 1980b), and
oocytes from superovulated animals, although still synthesizing proteins,
no longer synthesize ZP proteins (Shimizu et al., 1983).
Using an immunohistochemical method, Leveille et al. (1987)
indicated that the native anti-ZP antibody binding material of hamster ZP is
synthesized in the oocyte itself and not in the granulosa cells.
Immunocytochemical localization methods have been used to identify ZP
antigens in the cytoplasm of hamster oocytes (Leveille et al. 1987) and
rabbit oocytes (Wolgemuth et al. 1984). These studies indicate that at least
a portion of the ZP is produced in the oocyte.
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Many investigations attempted to characterize the constituent
macromolecules of the ZP. These studies led to the conclusion that there
are

marked

variations

in

the

morphological,

biochemical,

immunochemical, and physiochemical properties of the constituent
glycoproteins of the ZP in different mammalian species (Bleil and
Wassarman, 1980 a-c; Dunbar et al., 1981, 1985; Sacco et al. 1981; Drell
and Dunbar, 1984; Timmons et al., 1987; Yurewicz et al., 1987; Maresh
and Dunbar, 1987).
A major morphological variation occurs in the thickness of the ZP
between different mammalian species (Dunbar,

1983a).

The ZP

surrounding fully grown mouse oocytes is 7/*m thick and contains 3-4 ng
of protein, made up of three major glycoproteins termed zona protein one
(ZP1), zona protein two (ZP2) and zona protein three (ZP3) (Bleil and
Wasserman, 1980a; Shimizu et al., 1983). The three proteins appear to be
organized in a matrix of branched filaments (Greve and Wasserman,
1985).

Certain

chemical

and

enzymatic

treatments,

specifically

dithiothreitol and chymotrypsin, reduce the branched matrix to individual
filaments composed of both ZP2 and ZP3, suggesting that ZP1 is
responsible for the branching (Greve and Wasserman, 1985). Thus, the
ZP of a fully grown oocyte appears to be an ordered structure of filaments
composed of ZP2 and ZP3, either together or separate, and held together
by ZP1.
Hamster ZP proteins in reduced state are resolved into two
components of apparent molecular weights of 80 kd and 240 kd by SDSPolyacrylamide Gel Electrophoresis (SDS-PAGE).

By a second gel

9

electrophoresis in the same direction without SDS, a third band of an
apparent molecular weight of 150 kd appears (Ahuja and Bolwell, 1983).
Three major families of ZP proteins from human ZP (ZP1, 80-120
kd: ZP2, 73 kd: ZP3, 59-65 kd) and rabbit (ZP1, 100-118 kd; ZP2, 83-110
kd; ZP3, 80-92 kd), and four major families from squirrel monkey (ZP1,
63-78 kd; ZP2, 63-70 kd; ZP3, 47-51 kd; ZP4, 43-47 kd) can be separated
by two-dimensional SDS-PAGE under reducing conditions.

A similar

result was obtained with rabbit ZP proteins by Dunbar et al. (1981). As
previously described, ZP1 is responsible for cross-linking the fibrillar ZP2
and ZP3. Recently, Wassarman (1987a,b) described receptors present in
ZP3 which are responsible for species specificity of sperm binding.
Recently a fourth glycoprotein has been isolated from the ZP of oviductal
eggs from the golden hamster.

This glycoprotein, termed zona protein

zero (ZP0) is produced by the epithelial cells of the oviduct and was found
to be in the weight range of 200-240 kd (Oikawa, 1989; Sakai et al.,
1988). During in vitro fertilization studies, it was found that antibodies
raised to ZP0 greatly inhibited sperm binding (Sakai et al., 1988).
The permeability of the ZP was the subject of ongoing study for
many years.

Austin and Lovelock (1958) believed that the ZP of the

rabbit, rat, and hamster are permeable to substances with a molecular
weight of 1,200 or less. This meant that the vitellus could be considered
directly accessible to all the known essential food components including
vitamins, to the majority of pharmacologically active compounds, and to all
natural steroid hormones.

It would not be accessible to most enzymes,

antigens, antibodies, or protein hormones (Austin, 1961).

It was later
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demonstrated (Anderson, 1967) that horseradish peroxidase (mol. wt.
40,000) penetrated through the ZP in the ovarian oocyte of the rabbit.
Simmons and Russell (1966) suggested that the ZP may be
impermeable to immunoglobulins, thereby protecting the embryo from the
potentially adverse effects of the maternal immune system. Heyner et al.
(1969) provided support for this theory, stating that immunoglobulins (mol.
wt. 150,000 - 900,000) might not be expected to pass through the ZP.
This statement is based on the observation that the development of eight
cell mouse eggs to the blastocyst stage is uneffected by the presence of
cytotoxic antibody plus complement in vitro.

However, Sellens and

Jenkinson (1975) indicated that the ZP of the mouse blastocyst was
permeable to high molecular weight immunoglobulins based on their
observation that ZP-enclosed embryos were destroyed when exposed to
serum fractions containing either IgG or IgM and complement.
The inner layers of the follicular cells, the granulosa cells, maintain
specialized contacts with the oocyte and assist in protein and nucleic acid
synthesis via metabolic transfer to the oocyte (Anderson and Albertini,
1976; Gilula et al., 1978; Heller et al., 1981; Brower and Schultz, 1982).
This may give a false impression as to the permeability of the ZP.
While a considerable amount of information is now available on the
structure and function of the mature ZP obtained from large ovarian
follicles or from ovulated ova with respect to their potential roles in the
fertilization process, few studies have been carried out to evaluate the
potential roles of the ZP proteins during follicular development or during
the onset of sexual maturation (Dunbar et. al., 1989).
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The ZP-encased oocyte residing in the developing follicle is bathed
in follicular fluid, a substance very similar in composition to serum and
previously demonstrated to contain immunoglobulins (Matousek et al.,
1986; Kay et al., 1985; Hussein and Bourne, 1984). The protein content
of human follicular fluid compares to that of blood serum (ManarangPangan and Menge, 1971; Shalgi et al., 1973; Perricone et al., 1990).
Although their results differed in respective ratios, all agreed, along with
Clark (1900) that follicular fluid appears to be mainly derived from blood
by transudation and not from granulosa cells. This provides evidence that
the basement membrane of the follicle presents little if any barrier to the
diffusion of substances from the theca into the follicle.
Perricone et al. (1990) found that the human follicular fluid
contained functionally active complement proteins in amounts similar to
those present in normal human serum. Numerous investigations (Sacco,
1981; Dunbar, 1983b) involving immunization of females with ZP antisera
indicated that ZP antibodies can indeed reach and combine with the ZP in
the follicle. ZP-encased eggs obtained from such immunized females have
all possessed ZP antibody on the ZP surface, as established by microscopic
or immunofluorescent procedures (Sacco, 1979; Sacco et al., 1983). This
indicates that the ZP is accessible to blood-borne proteins.
Shalgi et al. (1973), using Ouchterlony double diffusion tests,
reported the presence of both IgG and IgA in human follicular fluid.
Proteins with a molecular weight of 150,000, such as IgG were present in
lower concentrations than normal serum.

Proteins of higher molecular

weight, such as IgM (900,000 mol. wt.) were undetectable in follicular
fluid, or detectable in trace amounts only.

The oocyte is not in direct
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contact with the follicular fluid, but rather is separated from it by the ZP
and the cumulus oophorus.

Since follicular fluid was found to contain

components of the complement fixation pathway, the ZP may be the only
remaining barrier for protection of the oocyte.
The ability of molecules to pass through the ZP may depend not only
on molecular weight, but also on molecular configuration, degree of
aggregation, or the charge characteristics of the molecule in relation to the
ZP itself. Hastings et al. (1972) stated that the ZP might exclude some
molecules on the basis of binding with these molecules or possibly by
charge effects. This was supported by experiments which suggested that in
the rat and mouse the ZP contained compounds that could give rise to a net
negative charge within the ZP which would impede the entry of molecules
also bearing a net negative charge (Sellens and Jenkinson, 1975).
Few studies have been conducted on the antigenic composition of
mammalian ovaries and eggs, however, with the advent of in vitro
fertilization many investigators have focused their research on this area.
Autoantibodies to the ZP have been found in the serum of infertile women
(Shivers and Dunbar, 1977; Mori et al., 1979; and Buckshee and Mhaskar,
1984). These findings provide further evidence that the ZP is accessible to
the serum proteins of the maternal blood circulatory system. This is an
indication that the ovary and its components can be affected by the
maternal immune system.
If the interaction between the immune system and the ovary, and
more specifically the follicle and oocyte, are to be investigated, it becomes
necessary to provide some background information on aspects of the
immune system deemed pertinent to this study.
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Immunoglobulins

are

glycoproteins

polypeptide and 4-18% carbohydrate.

composed

of

82-96%

The polypeptide component

possesses almost all of the biological properties associated with antibody
molecules.

Antibodies (immunoglobulins) are bifunctional molecules in

that they bind specifically with antigens and also initiate a variety of
secondary phenomena, such as complement fixation and histamine release
by mast cells, which are independent of their specificity for antigens.
Each immunglobulin contains at least one basic unit, or monomer,
comprised of four polypeptide chains. One pair of identical polypeptide
chains contains approximately twice the number of amino acids, i.e.

is

approximately twice the molecular weight, of the other pair of identical
polypeptide chains.

The chains of higher molecular weight are thus

designated heavy (H) chains and those of lower molecular weight
designated light (L) chains.

Each polypeptide chain contains an amino-

terminal portion and a carboxy-terminal portion, the former termed the
variable (V) region and the latter termed the constant (C) region. These
terms denote the heterogeneity or variability in the amino acid residues
between the two regions.
The part of the antibody molecule that binds antigen is formed only
by a small number of amino acids in the V region of H and L chains and
these amino acids are brought into close relationship by the folding of the
V region.
There are five classes of immunglobulins, designated IgG, IgA,
IgM, IgD, and IgE.

They are defined by antigenic differences in the

constant regions of the heavy chains.
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Enzymatic digestion of an IgG molecule using papain yields two
antigen-binding fragments (Fab) and one crystallizable fragment (Fc). The
digestion by papain takes place in an area of the molecule known as the
hinge region. The hinge region is defined as the area of the H chain in the
C region between the first and second C region domains.

This area is

more flexible and is more exposed to enzymes and chemicals.
Enzymatic digestion of a molecule of IgG using the enzyme pepsin
yields one F(ab)'2 molecule and small peptides. The F(ab)'2 molecule is
composed of two Fab units and the hinge region, with intact inter-H chain
disulfide bonds. The later are left intact since pepsin cleaves the molecule
on the carboxy-terminal side of these bonds (for a review of
immunoglobulins see Goodman, 1987).
In adult humans IgG constitutes approximately 75% of the total
serum immunoglobulin.

The IgG class is made up of four subclasses

designated IgGl, IgG2, IgG3, and IgG4. Immunoglobulin G is the only
class of immunoglobulin that is known to cross the placental barrier and
this phenomena is believed to be a receptor mediated event (Goodman,
1987; Steward, 1974). Immunoglobulin G Fc receptors have been isolated
and it is believed that these receptors play a role in the transport of IgG
(Van de Winkel and Anderson, 1991). Rodewald and Kraehenbuhl (1984)
described a receptor-mediated endocytosis in which large amounts of intact
IgG were transported across the intestinal epithelium.
It is interesting to note that IgG does not appreciably cross the
choriocapillaris of the choroid to accumulate in Bruch's membrane (Pino
and Thouron, 1983).

This suggests that capillaries in general may not

necessarily be permeable to IgG.

There is a several-fold rise in the
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microvascular permeability to IgG in the testis of rats at 27-30 days of age
(Pollanen and Setchell, 1989). It is interesting that this rise in permeability
coincides with the beginning synthesis of an interleukin-1-alpha-like factor
by the Sertoli cells (Syed et al., 1988). Interleukin-1 is known to regulate
the functions of endothelial cells in other tissues (Bevilacqua et al., 1985).
Two additional proteins that are pertinent to this study are albumin
and female protein (FP).

Serum albumin is a highly flexible molecule

containing 575 amino-acids combined to give an overall molecular weight
of 65,000. Albumin is characterized by its extreme solubility in water, its
negative charge of 19 at pH 7.4, and its lack of a carbohydrate moiety
(Rothschild et al., 1972).

It is known that in addition to its role in

maintaining the colloid osmotic pressure of plasma and interstitial fluid,
albumin is an important carrier for various molecules such as fatty acids,
testosterone, estradiol, and thyroid hormones. These molecular complexes
(ligands) are then presented to the surfaces of the target cells (Corvol and
Bardin, 1973; Hutter et al., 1984; Ockner et al., 1983).
Estimates of the lymph/plasma albumin ratio revealed that the
amount of albumin passing from the plasma into interstitial fluid varies
significantly from organ to organ (Everett and Simmons, 1958; Pino and
Thouron, 1983; Sharpe, 1979; Williams and Greener, 1984; Williams et
al., 1981; Yokota, 1983). Considering the different types of endothelium
found in these various organs, no firm correlation can be established
between the endothelial structure and the rate of albumin transport. Other
properties of the endothelial cell may account for the difference in the rate,
speed, and kinetics of albumin uptake between various tissue (Ghitescu et
al., 1986). Albumin transport through endothelial cells via transendothelial
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channels (connective transcytosis) and plasmalemmal vesicles (vectoral
transcytosis) has been described (Ghitescu, 1986; Simionescu, 1981). Sage
et al. (1984) described a unique albumin binding glycoprotein synthesized
by bovine, porcine, and human endothelial cells in culture.
Albumin binding sites have been demonstrated on the surfaces of
liver and heart cells (Ockner et al., 1983; Hutter et al., 1984) as well as
for endothelial cells of the capillaries (Ghitescu et al., 1986; Schnitzer et
al., 1988).

The binding of the albumin-ligand complex to membrane

receptors of tissues triggers endocytosis of the hormone-receptor complex
either with or without the internalization of the albumin (Szego, 1975;
Shteri et al., 1982; Ockner et al., 1983). Albumin may also be significant
in its ability to remove ligands from target cells, and by this mechanism
may mediate functions of steroid-producing and steroid-responding cells
(Krishna and Spanel-Borowski, 1989).
Female protein (FP) is an alpha globulin found in the serum of the
female Syrian (golden) hamster, Mesocricetus auratus (Coe, 1977; Coe et
al., 1981).

Female protein is also found in the Kurdistan hamster,

Mesocricetus brandti, but is not found in Chinese, Armenian, European, or
Djzungerian hamsters (Coe et al., 1981). Female protein, produced in the
liver (Coe and Ross, 1985), is a pentamer approximately 13 nm in
diameter and has a molecular weight of 150,000.

The native molecule

consists of five 30,000 mol. wt. subunits noncovalently assembled to form
the 150,000 mol. wt. parent molecule (Coe et al., 1981).
Although FP is detected in conspicuous amounts in normal female
hamster serum (2mg/ml), it is not detectable by simple gel diffusion in
normal serum from adult males (Coe et al., 1981).

The protein is,
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however, detectable for a transient period in young male hamsters (Coe,
1977; Coe et al., 1981).
Castration of adult males results in a 50-fold increase in the serum
levels of FP (Coe and Ross, 1990), while administration of testosterone to
castrated males results in a concomitant decrease in serum levels of FP
(Coe, 1977; Coe et al., 1981; Coe and Ross, 1990). This would indicate a
suppressor function of the testicles via testosterone on serum FP in adult
male hamsters.
Ovarectomized (castrated) female hamsters show no significant drop
in serum levels of FP, indicating that intact ovaries are not required for
maintenance of normal serum FP levels. Concomitantly, female hamsters
injected with testosterone show a significant decrease in serum FP levels,
indicating that testosterone has a suppressor effect on serum FP in females
as well as males, i.e. a primary suppressor effect of an androgen (Coe,
1977; Coe et al., 1981).
Female protein is remarkably similar to two other serum proteins
found in other animals, C-reactive protein (CRP) and serum amyloid
protein component (SAP). In fact, FP appears to represent the CRP-SAP
homologue in Syrian hamsters (Coe et al., 1981). In contrast to FP, CRP
and SAP are normally present in low serum concentrations and are not
known to be under sex-hormone control (Coe, 1977).

Amino-terminal

sequence data shows a clear homology between FP and SAP in which 19 of
23 identifiable residues (83%) were identical. Since CRP and SAP have
been shown to be homologous (Osmand et al., 1977; Levo et. al., 1977;
Coe and Ross, 1983) and FP and SAP exhibit 83% homology, the three
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proteins appear to have evolved from the same ancestral gene (Coe et al.,
1981).
Human CRP is the classic acute-phase reactant, which can increase
almost 1000-fold in serum levels after nonspecific inflammatory stimuli
(Coe et al., 1981). Numerous biological functions have been shown for
CRP including activation of complement (Siegel et al., 1974; Kaplan and
Valanakis, 1974), interaction with T lymphocytes (Croft et al., 1976) and
platelets (Fiedel and Gewurz, 1976), and enhancement of phagocytosis
(Kindmark, 1971; Pepys et al., 1978). In contrast, SAP is found in normal
human and mouse serum, but only in mice does it increase as a typical
acute-phase reactant after inflammatory stimuli (Pepys et al., 1979).
Once bound to C3, CRP activates the classical complement pathway
via C3 conversion independent of the presence of specific antibody or
immunoglobulin (Kaplan and Volanakis, 1974; Pepys et al., 1978). The
CRP analog in the rabbit, CxRP, was shown to stimulate leukocyte
migration (Wood, 1951), facilitate phagocytosis (Hokama et al., 1962;
Kindmark, 1971, 1972), signal enhanced immune response (Wood, 1953),
and induce lymphocyte-blast formation (Hornung and Friechi, 1971).
Hamster FP, the homologue of CRP and SAP, exhibits some acutephase reactivity. In male hamsters there is a moderate increase in serum
FP after nonspecific inflammatory stimuli (Coe, 1977; Coe et al., 1981).
However in female hamsters FP serum levels show a dramatic decrease in
serum levels during an acute-phase response (Coe and Ross, 1983).
Hamster FP also activates the classical complement pathway at the level of
Cl (Coe and Ross, 1985). Immunoglobulin G and female protein are both
implicated as initiators of the complement fixation pathway.
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Complement is a complex biological system made up of nine protein
components, designated C1-C9.

The first of these components, when

activated by immune complexes, activates the next component which in
turn activates the next component in the sequence and so on thus producing
a cascade effect. The end result of complement fixation is lysis of cell
membranes leading ultimately to cell death. In addition to its role in cell
lysis, the complement system also produces proteins which promote
chemotaxis, i.e. the attraction of polymorphonuclear phagocytes, as well as
proteins which enhance opsonization.
Briefly, the cascade system is described by Steward (1974).

The

initial step in the activation of the complement sequence by antigenantibody complexes is the binding of Cl to active sites on the Fc region of
the antibody which has been produced as a result of immune complex
formation. The Cl recognition unit consists of three subunit types: Clq,
C lr and C ls, and the reaction with the altered antibody occurs through the
Clq component, which can bind up to five IgG molecules. This binding
results in C lr activating Cls. The active form of C ls is an enzyme the
substrates of which are components C4 and C2.

It first catalyzes the

binding of C4 to the cell and then the binding of C2 to the bound C4. This
complex (C42) is termed C3 convertase which has C3 as its substrate. At
this stage two events occur as a result of C3 convertase activity on C3.
Fragments of C3 called C3a are released and these have anaphylotoxin
activity,

for

histamine

release,

and

also

are

chemotactic

for

polymorphonuclear phagocytes. The major fragment of C3, called C3b, is
transferred to the target cell membrane, and is recognized by the C3
binding sites of macrophages leading to immune adherence and subsequent
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phagocytosis.

C3b also modifies the C42 enzyme to produce the C423

enzyme. This acts on C5 which then interacts with C6 and C7 resulting in
the binding of C567 to the membrane. Also at this stage, further fragments
with chemotactic and anaphylatoxin activity are produced. As previously
described, it is known that the complement fixation pathway need not be
activated by an antigen-antibody complex, but rather may be activated by
proteins such as CRP, CxRP, SAP, and FP. Finally C8 and C9 become
attached to the membrane and a lesion is produced.

(For an in depth

review of the complement fixation pathway see Cooper, 1987).
Since the oocyte develops in a manner similar to the spermatocyte,
and the spermatocyte has been shown to produce surface proteins that are
antigenic to the maternal immune system, one might assume that the oocyte
also produces proteins specific to its cell coat. These proteins would label
the oocyte as a foreign cell, thus a barrier between these cells and the
maternal immune system is essential.

This study proposes that the ZP

provides the morphological basis of this blood-oocyte barrier.

Further

speculation is made that the oocyte plays a role in its own protection by
production of complement inhibitors.

MATERIALS AND METHODS

Female golden hamsters (Mesocricetus auratus) were kept on a
14:10 light dark cycle at 22°C. Only hamsters that had three consecutive 4
day estrous cycles were used in these studies. Ovulation occurs late on
day four of the estrous cycle. Day one of the estrous cycle is characterized
by a conspicuous vaginal discharge. Animals were checked for discharge
between 0700 and 0900 hours. All animals used in this study were in the
weight range of 108-230 grams.

Animals were anesthetized by

intraperitoneal (i.p.) injection of phenobarbitol (Nembutal) at lOmg/lOOg
body weight.

Indirect Immunolabelling Technique
Hamster ovaries were harvested every four hours throughout the
estrous cycle beginning at 0200 hours on day one. At the appropriate time,
animals were injected i.p. with Nembutal (lOmg/lOOg body weight). Upon
deep anesthesia, the thoracic and abdominal cavities were opened by a
single incision. An 18 gauge pediatric i.v. cannula was passed down the
descending aorta to the level of the diaphragm.

The right atrium was

incised to allow for drainage of blood and perfusate from the animal.
Infusion was carried out via a Harvard infusion pump equipped with
a 50ml disposable syringe. Perfusion via an infusion apparatus was chosen
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over injection by hand because the former allows for control of
temperature

and

intraarterial

pressure,

is

documentable,

and

is

reproducible whereas manual injection does not provide this regulation
(Christofferson and Nilsson, 1988).

Approximately 50ml of 0.1M

phosphate (P04) buffer (pH 7.4) was perfused at the rate of 15.3 ml/minute
to allow for flushing of the blood from the vessels. This was immediately
followed by approximately 150ml of 1% paraformaldehyde in 0.1M P 04
buffer (pH 7.4) to obtain optimal preservation of antigenic tissue sites.
Ovaries were immediately removed, sectioned into four pieces, and further
processed using a modification of the technique used by Beckstead (1985).
This technique employed the use of a glycol methacrylate embedding
medium, which provides for better morphology than can be obtained using
paraffin. The technique, carried out at 4°C, is as follows: 1) fix for a
minimum of 6 hours in 4% paraformaldehyde in 0.1M P 0 4; 2) wash for
one hour in 0.1M P 0 4 buffer with 2% sucrose and 50mM NH4C1, repeat
twice; 3) wash for one hour in 0.1 M P 04 buffer with 50mM NH4C1, repeat
once; 4) place in JB4 Plus (glycol methacrylate) infiltration medium for a
minimum of eight hours; 5) embed with JB4 Plus embedding medium
(Polysciences, Inc.) in number 0 gelatin capsules. A ratio of 1:10 catalyst
(organic peroxide) to infiltration medium was found to yield blocks of a
desirable hardness for sectioning.

Upon complete polymerization the

tissue was sectioned at approximately 3/rni on a Sorval Porter-Blum MT2B ultramicrotome using glass knives. The sections were placed on a drop
of water on glass microscope slides which were then allowed to air dry
overnight.
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Immunohistochemical procedures were performed in the following
order and, unless otherwise specified all incubations were carried out in a
dark, moist chamber at room temperature.

Each successive step was

followed with a rinse of phosphate buffered saline (PBS): 1) etch plastic
with 10% H20 2 for 15 minutes to expose tissue; 2) apply 0.25% porcine
trypsin in Saline A (Gibco, Santa Clara, CA), pH 7.6 for 10 min at 37°C
to unmask cross-linked binding sites (Huang, 1976);

3) apply carrier

solution for 30 minutes to bind any nonspecific binding sites;

4) apply

primary antibody diluted at 1:400 in carrier solution. Primary antibodies
used were goat anti-hamster IgG or goat anti-mouse IgA (Cappel);

5)

apply carrier solution for 30 minutes; 6) apply secondary antibody for 1
hour.

Secondary antibodies used were rabbit anti-goat IgG peroxidase-

conjugated Fab2 fragments diluted at 1:20 in carrier solution, or rabbit
anti-goat IgG conjugated with fluorescein isothyocyanate (FITC) diluted at
1:32 in carrier solution; 7) coverslip FITC treated slides with mounting
medium and seal the edges with nail polish.
Peroxidase conjugated tissue was rinsed with PBS and the peroxidase
reaction was developed as follows: 1) incubate with 0.01% (0.5mg/ml)
3,3'-diaminobenzidine (DAB) in 0.1M phosphate buffer for 10 min at
37°C; 2) incubate with 0.01% DAB in 0.1M phosphate buffer with 0.1%
H20 2 for 5 min at 37°C; 3) counterstain with Harris' hematoxylin for 6
min, blue in tap water for 2 min, dehydrate in ascending grades of ethanol
and coverslip using Permount.
The carrier solution was prepared by mixing 1ml of normal serum
(serum from the same species in which the secondary antibody was
produced), one gram of bovine serum albumin, 1.5ml of 20% Triton

24

X-100, and 97.5ml of PBS according to A Practical Guide to
Immunohistochemistry, published by Pel-Freez Clinical Systems.

The

bovine serum albumin aids in binding to nonspecific binding sites and the
Triton X-100 is used to disrupt cellular membranes.
Mounting medium used for coverslipping fluorescent labelled tissue
was a mixture of 2.42g tris-base/100 ml distilled water at pH 8.5, 12ml
Tris at pH 8.5, 4.76ml dimethylsulfoxide (DMSO), 6ml methanol, and
2.4g

of 20.30 polyvinyl alcohol

(PVA).

Just before use,

p-

phenylenediamine (PPD) was added at lmg/ml to prevent photobleaching
(Soo Siang Lim-Spiker, personal communication). After coverslipping, the
edges were sealed with nail polish. A minimum of two hours should pass
before viewing.

It is also important to store slides prepared for

fluorescence microscopy in a cool, dark container, to prevent premature
decay of fluorescence.
Controls for the immunohistochemical staining procedure were
conducted using an antibody substitution technique in which PBS was
substituted for antibody. Three controls were carried out such that one
slide was incubated with primary antibody only, one was incubated with
secondary antibody only, and one was incubated having no exposure to
antibody.
A series of immunolabelling experiments was also carried out on
selected tissue using rabbit anti-hamster IgG, rabbit anti-hamster female
protein, and rabbit anti-hamster albumin as the primary antibody diluted
1:400 in carrier solution. Tetramethylrhodamine isothiocyanate (TRITC)conjugated goat anti-rabbit IgG diluted 1:40 in PBS or peroxidase-
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conjugated goat anti-rabbit IgG diluted 1:20 in carrier solution was
employed as the secondary antibody.
An alternate technique for immunohistochemical labelling employing
microwave irradiation was adapted for use on tissues. This technique has
been used in the past with some success and greatly reduces the time
required for immunohistochemical staining (Chiu and Chan, 1987, Leong
and Milios, 1986, 1990).

Microwave irradiation was carried out in a

Litton Minutemaster, 700 watt microwave oven equipped with a Nordic
Ware Micro-Go-Round Plus carousel, with roasting tray and cover. Slides
were placed on a Plexiglass sheet in the roasting tray and distilled water
was poured into the tray to completely cover the bottom. This allowed for
even heating of the tissue while providing a moist, covered environment.
Immunohistochemical procedures were performed in the following
order, with each successive step followed by a PBS rinse: 1) apply 10%
H20 2 and microwave on setting one for 1 minute 10 seconds, let stand for
3 minutes 50 seconds; 2) apply 0.25% porcine trypsin in saline A and
microwave on setting one for 1 minute 10 seconds, let stand for 3 minutes
50 seconds; 3) apply carrier solution and microwave on setting three for 1
minute 10 seconds; 4) apply primary antibody diluted to 1:400 in carrier
solution, microwave on setting two for 1 minute 10 seconds;

5) apply

secondary antibody diluted to 1:20 in carrier solution, microwave on
setting two for 1 minute 10 seconds, let stand for 3 minutes 50 seconds.
Fluorescent labelled tissues were then coverslipped with mounting
media as previously described, and peroxidase treated slides were
developed at 37°C in a water bath, counterstained, and coverslipped with
permount as previously described.
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The microwave immunohistochemical staining procedure provided
results similar to the original room temperature technique requiring one
third of the time, however the labelling did not appear to be consistent
from one section to another nor was the tissue evenly labelled.
The peroxidase treated tissue was examined and photographed on a
Olympus BH-TU microscope equipped with an 80a (daylight) filter. FITC
and TRITC

treated tissues were examined for fluorescence and

photographed on a Nikon Microphot FX Episcopic Fluorescent Microscope
equipped with a Nikon B-1E filter cube for viewing FITC and a Nikon G1B filter cube for viewing TRITC.

The B-1E filter has the following

illumination properties: excitation filter = 470-490 nm, barrier filter =
520-560 nm, dichroic mirror = 510 nm. The G-1B filter has the following
properties: excitation filter = 546 nm, barrier filter = 590 nm, dichroic
mirror = 580 nm.
To rule out the possibility of this phenomenon being a staining
artifact of the ovary, ovulated oocytes were stained using the same
peroxidase techniques previously described. Oviductal oocytes and flushed
oocytes were studied and in each case these oocytes were found to have
what appeared to be an intact ZP. Oviductal oocytes were localized by
sectioning through the oviduct harvested from an animal on day one of the
estrous cycle.

The oviduct had been fixed and embedded in a manner

identical to the ovaries, as previously described.
Ovulated oocytes were obtained by flushing the oviducts of a
superovulated hamster. Superovulation was accomplished according to the
method of Kan et al. (1990).

Briefly, 25 international units (IU) of

pregnant mare serum gonadotropin were injected i.p. at 0800 hours on day
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one of the estrous cycle. Forty eight hours later the animal was injected
i.p. with 25 IU of human chorionic gonadotropin. Seventeen hours later
the animal was euthanized by overdose of Phenobarbitol (Nembutal) and
the oviducts were removed and flushed with PBS. The cumulus masses
were collected and fixed in 4% paraformaldehyde in 0.1M P 04 buffer for
1.5 hours at 4°C.
The tissue was then placed in JB4 Plus infiltration medium at 4°C
for four hours, and then placed in number 0 gelatin capsules filled with
JB4 Plus infiltration medium plus catalyst.

The capsules were then

centrifuged (Britton et al. 1991) for three minutes to force the tissue to the
bottom of the gelatin capsules. The embedding medium was then allowed
to polymerize overnight.
Thick sections (2/im) were cut on a Sorval Porter-Blum MT2-B
ultramicrotome using a glass knife and placed on drops of water on glass
microscope slides which were subsequently dried on a hot plate. Sections
were then stained with toluidine blue and examined via standard light
microscopy. Serial sections were examined until oocytes were visualized,
at which time sections were cut, floated on water on glass slides and
allowed

to

air

dry

overnight.

These

slides

were

then

immunohistochemically stained following the standard staining technique
previously described. Goat anti-hamster IgG diluted to 1:400 was used as
the primary antibody and peroxidase-conjugated rabbit anti-goat IgG
diluted at 1:20 was used as the secondary antibody.
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Electron Microscopy
Ovaries were fixed in vivo by means of infusion via a Harvard
infusion pump, all infusion being at the rate of 15.3 ml/minute via an 18
gauge cannula placed in the descending aorta or by cardiac puncture.
Following incision of the right atrium, 50ml of 0.15M cacodylate buffer,
pH 7.2, was infused to flush blood from the vessels.

Immediately

following the flushing, 150ml of cacodylate buffered fixative was infused.
This fixative was a modification of that used by Doerr-Schott and Lichte
(1986) such that the final concentrations of the components were 0.5%
paraformaldehyde, 0.75% glutaraldehyde, and 0.06M cacodylate buffer.
Upon completion of the infusion the ovaries were removed, sectioned into
four pieces, and placed in fixative for 24 hours at 4°C.
The tissue was

removed from the fixative,

dehydrated in

dimethylformamide (DMF), and prepared for embedding in lowicryl K4M
(Electron Microscopy Sciences) using the following schedule (Altman,
1984):
50% DMF..................

20 minutes

75% DMF.................

20 minutes

90% DMF.................

20 minutes

2:1 DMF:lowicryl........... 60 minutes
1:1 DMF:lowicryl........... 60 minutes
100% lowicryl................ 24 hours at 4°C
Following the 24 hour infiltration, fresh lowicryl, mixed according to the
manufacturers

specifications,

was

used

for

tissue

embedding.

Polymerization of the lowicryl was carried out in a foil-lined Styrofoam
chamber equipped with a black light (two 18" tubes, 25 watts, General
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Electric) which emitted a wavelength of 360nm. The tissue was placed in
number 0 gelatin capsules filled with lowicryl and suspended via thin wire
at a lamp to tissue distance of 10 cm, and subjected to UV light for one
hour at 4°C.
The tissue blocks were thick sectioned on a Sorval Porter-Blum
MT2-B ultramicrotome using glass knives. These sections were placed on
glass slides and stained with toluidine blue.

Individual follicles were

localized under the microscope and the blocks were trimmed to the area of
a follicle for thin sections. Thin sections (gold to silver) were cut using a
diamond knife and were transferred to 400 mesh nickel grids.
The grids were immersed in drops of 0.01M PBS with 5%
ovalbumin for 10 minutes. The grids were then transferred without rinsing
to drops of rabbit anti-hamster albumin diluted 1:400 with a solution of
50mM Tris HC1 and 150mM NaCl at pH 7.4 where they were allowed to
incubate overnight in a dark moist chamber at 4°C. The grids were then
rinsed three times by placing them in drops of 0.01M PBS for ten minutes.
Following blotting on lint-free paper the grids were transferred into drops
of 15nm colloidal gold conjugated to protein A (Janssen) for 30 minutes.
The colloidal gold was diluted at 1:20 with 1% ovalbumin in 0.02M PBS,
pH 7.4. The grids were then rinsed three times in drops of 0.02M PBS at
pH 7.4 for five minutes followed by a final rinse in distilled water for ten
minutes. The grids were then counterstained by immersion in 1% uranyl
acetate in 50% ethyl alcohol for 5.5 minutes, rinsing in distilled water and
immersion in 0.018% lead citrate for 5.5 minutes and a final rinse in
distilled water.
described earlier.

Control tissue was treated with antibody substitution as
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Grids were viewed and photographed on a JEOL JEM 100S
transmission electron microscope.

Injection of Labelled Immunoglobulin
Twenty mg samples of chromatographically purified Hamster IgG
(Cappel) were reconstituted with 2ml of 0.1M Na2HP04 (pH 8.5) and the
pH was rapidly adjusted to 9.5 with 0.05M NaC03. Three tenths of a
milligram of FITC was added and the pH again was rapidly adjusted to 9.5
with 0.05M NaC03. This mixture was allowed to react for one hour in the
dark at room temperature.

The solution was then separated by gel

filtration through an 8ml column of Sephadex G-25 which had been swelled
in physiological saline. Eight 1ml fractions were collected and analyzed in
a Beckman DU-50 Spectrophotometer. Fractions were pooled such that a
solution

with

a

final

concentration

of

5mg/ml

was

obtained.

Spectrophotometric analysis estimated an average FITC to IgG ratio of 3:1.
Injection of 1ml of FITC-conjugated hamster IgG solution (5mg/ml)
was carried out via either the abdominal aorta or the femoral vein. One
animal was injected at 1000 hours for each of the four days of the estrous
cycle. The injection mass was allowed to circulate for one hour, at which
time the ovaries were removed, sectioned into two pieces, and placed in
4% paraformaldehyde in 0.1M phosphate buffer for four hours. Control
animals were injected i.v. with 1ml of FITC/physiological saline at the
same FITC concentration (0.9/zM) as the IgG/FITC solution.

This

injection was allowed to circulate for one hour before harvesting the
ovaries. One animal from day three of the estrous cycle was injected with
IgG/FITC and the circulation time was reduced to 30 minutes.
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The tissue was removed from fixative and dehydrated using standard
ethanol dehydration which was completed in two changes of 100% Hemo
De (Fisher) for 30 minutes each. The tissue was then passed through a
50/50 mixture of Hemo De/Paraplast for 30 minutes and then through two
changes of 100% Paraplast for 30 minutes each before final embedding in
100% Paraplast.
Paraplast sections were cut at 6/xm, floated on a water bath of
distilled water and gelatin, and mounted on glass slides. The sections were
then deparaffinized using two changes of xylene for three minutes each and
then rinsed with 100% ETOH. The slides were immediately coverslipped
for fluorescence microscopy, as previously described, sealed with nail
polish, and placed in the dark at 4°C for at least two hours before viewing
on the Nikon Microphot FX Episcopic Fluorescent Microscope.

RESULTS

Folliclular development spans more than one estrous cycle and it is
possible to find virtually any stage of follicular development at any time
throughout the estrous cycle. In reviewing the ovary sections used in this
study, follicles of virtually all stages of development, from primary
unilaminar to antral follicles, were seen at every time period sampled. An
exception was the occurrence of mature graffian follicles, which were
visualized mainly in the later time periods (1800 and 2200 hours) on day
four of the estrous cycle.
Indirect Staining Technique
Treatment of ovary sections with goat anti-hamster IgG (GAH-IgG)
as a primary antibody followed with peroxidase or FITC-conjugated rabbit
anti-goat IgG (RAG-IgG) as a secondary antibody resulted in labelling of
the ZP and remnants of the liquor folliculi.
labelling

in primary unilaminar follicles

Zonae pellucidae exhibit
and continue throughout

successive stages of development. The ZP of atretic follicles also label.
The liquor folliculi did not label in many antral follicles, and in others
labelling appears to be directed toward one side of the antrum.
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Day one, lOOOh
Follicles from this stage of the cycle exhibit intense labelling of the
ZP when treated with GAH-IgG followed by FITC-conjugated RAG-IgG
(Figs. 1 and 2). Control tissue (treated with FITC-conjugated RAG-IgG
alone) did not exhibit labelling as seen in an ovary harvested at lOOOh of
day two (Fig. 4).

Day one, 1400h
Large follicles found in ovaries in this stage treated with GAH-IgG
followed by FITC-conjugated RAG-IgG exhibit intense labelling of the ZP
with a less intense labelling in the space between the granulosa cells (Fig.
3).

High power magnification of ovary sections reveal a precise

localization of the peroxidase reaction product over the ZP when treated
with GAH-IgG followed by peroxidase-conjugated RAG-IgG (Figs. 5 and
7).

Similar examination of control tissue (treated with peroxidase-

conjugated RAG-IgG alone) exhibited a faint labelling over the area of the
ZP (Figs. 6 and 8).

Day two, 0200h
Follicles at this stage of the estrous cycle exhibit labelling over the
ZP when treated with GAH-IgG followed by peroxidase-conjugated RAGIgG.

This can be seen in primary unilaminar follicles as well as in

multilaminar primary follicles (Fig. 9).

Control tissue, consisting of

sections through the same follicles exhibits only faint labelling when
treated with peroxidase-conjugated RAG-IgG (Fig. 10).
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Day two, lOOOh
Labelling of the initial stages of ZP formation is seen in a primary
unilaminar follicle in an ovary harvested at this stage of the estrous cycle
when treated with GAH-IgG and peroxidase-conjugated RAG-IgG (Fig.
11).

Multilaminar follicles in ovaries from this sample time exhibit

labelling of the ZP when treated with GAH-IgG followed by either
peroxidase or FITC-conjugated RAG-IgG (Figs. 13 and 14).

Control

tissue from this sample period did not exhibit labelling when treated with
FITC-conjugated RAG-IgG alone (Fig. 4).
Day two, 1400h
Ovaries harvested at this stage of the estrous cycle reveal labelling of
the ZP in unilaminar primary follicles (Fig. 12) and multilaminar primary
follicles (Fig. 15) treated with GAH-IgG followed by peroxidaseconjugated RAG-IgG.

Control tissue treated with peroxidase-conjugated

RAG-IgG show faint labelling (Fig. 16).

Tissue from this time period

treated with goat anti-mouse IgA (GAM-IgA) followed with peroxidaseconjugated RAG-IgG show faint labelling of the ZP in follicles ranging
from unilaminar primary to multilaminar primary (Figs. 17 and 18).

Day three, lOOOh
Zona pellucida in multilaminar follicles in ovaries harvested at this
stage of the estrous cycle exhibit intense labelling when treated with GAHIgG followed with peroxidase-conjugated RAG-IgG (Figs. 19 and 20).
Similar results were seen in follicles harvested at day three, 1400 hours
(Figs. 21 and 22).
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Day four, 1400h
Ovaries harvested at this stage of the estrous cycle contain
multilaminar follicles with ZP which exhibit labelling when treated with
GAH-IgG followed by FITC-conjugated RAG-IgG (Figs. 23 and 24).

Day four, 2200h
Figure 25 demonstrates labelling of a multilaminar follicle in an
ovary treated with GAM-IgA followed with peroxidase-conjugated RAGIgG.

Similarly, the ZP of another multilaminar follicle labels intensely

when treated with GAH-IgG and peroxidase-conjugated RAG-IgG (Fig.
26).
Immunohistochemical staining procedures conducted with antibodies
to hamster IgG, FP, and albumin which were raised in rabbit instead of
goat, yielded results similar to the above.

Ovary sections treated with

rabbit anti-hamster FP followed by peroxidase-conjugated goat anti-rabbit
IgG exhibit labelling of ZP (Fig. 27) and liquor folliculi.

Treatment of

tissue with rabbit anti-hamster albumin followed by peroxidase-conjugated
goat anti-rabbit IgG reveals intense labelling of the ZP (Fig. 28) and liquor
folliculi.
ZP of oviductal oocytes and oocytes flushed from the oviduct exhibit
labelling when treated with GAH-IgG followed by peroxidase-conjugated
GAR-IgG.

Electron Microscopy
Using the protein A gold technique to label the ZP was successful
with respect to albumin only.

Tissue that was treated with rabbit anti
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hamster IgG as a primary antibody followed by treatment with Protein A
gold conjugate with 15nm gold particles (PAG-15) did not yield positive
results in any ovarian tissue type. The same holds true for tissue in which
the primary antibody used was rabbit anti-hamster FP.

However, when

rabbit anti-hamster albumin is used as the primary antibody followed by
treatment with PAG-15 there is a remarkably specific localization of the
gold particles over the ZP (Fig. 29). Control tissue treated with PAG-15
only exhibited no labelling in the ovary (Fig. 30).

Fluorescein Conjugated Immunoglobulin Injection
To reiterate, fluorescein conjugated hamster IgG was injected i.v.
into hamsters from each day of the estrous cycle. The injected IgG was
allowed to circulate for specified periods of time, after which the tissue
was collected and paraffin embedded as previously described. Subsequent
tissue sections were viewed and photographed on a fluorescence
microscope.

Day one, lOOOh
Fluorescence studies of ovaries from this stage of the estrous cycle
reveal that within one hour of injection, the IgG progressed to the level of
the ZP (Figs. 31 and 32). Fluorescence is also seen in the liquor folliculi
and in patches between granulosa cells (Figs. 33) presumably denoting
initial formation of liquor folliculi.

Antral follicles at this time period

exhibit evidence of atresia (Fig. 34). Remnants of ZP seen at this stage of
the estrous cycle do not exhibit fluorescence (Fig. 34) as is the case in
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other stages of the cycle (Fig. 38). However, fluorescence is seen in ZP
remnants which still enclose remnants of oocytes or macophages (Fig. 37).

Day two, lOOOh
Examination of ovarian tissue from this stage of the estrous cycle
reveal comparable results to those seen on day one.

After one hour of

circulation the IgG progressed to the level of the ZP in small bilaminar
follicles (Fig. 35) as well as in multilaminar follicles. Patches of
fluorescence are seen between granulosa cells of some multilaminar
follicles (Figs. 36 and 37) presumably marking the initial formation of the
liquor folliculi.
Follicles which exhibit labelling of the liquor folliculi at this time
period also exhibit signs of atresia. Remnants of ZP of follicles from past
cycles exhibit relatively little labelling (Fig. 38).

Day three, lOOOh
Thirty minutes after injection of fluorescein labelled IgG at this stage
of the estrous cycle the IgG advanced to the level of the ZP, however there
appeared to be more fluorescence toward the outside of the ZP (Figs. 39
and 40). This suggests that thirty minutes may be near the lower limit of
time required for circulating immunoglobulin to reach the ZP.
Fluorescein labelled IgG injected at this stage of the estrous cycle,
when allowed to circulate for 1 hour exhibits localization in the ZP as well
as in the liquor folliculi of developing antral follicles (Fig. 41) and larger
antral follicles (Fig. 42).
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Day four, lOOOh
Ovaries harvested from animals injected at this stage of the estrous
cycle demonstrate localization of fluorescein labelled IgG in the ZP (Fig.
43) and in the liquor folliculi of antral follicles.
Control tissue injected with fluorescein in physiological saline does
not exhibit fluorescence outside of the blood vessels (Fig. 44).

DISCUSSION

The purpose of this study was to determine if the ZP functions as a
barrier, limiting access of humoral immune agents to the oocyte. This is
important in that the oocyte is capable of synthesizing "non-self" proteins
and may be recognized as foreign by the immune system.
Since the oocyte develops in a manner similar to the spermatocyte,
and the spermatocyte has been shown to produce proteins on its cell
surface that are antigenic to the host immune system, one might assume
that the oocyte also produces antigenic proteins specific to its cell coat.
Such proteins would identify the oocyte as a foreign cell, therefore these
cells must be protected against exposure to destructive elements of the
immune system.
Immunohistochemical labelling techniques were used to determine
the presence of IgG, FP, and albumin in the hamster ovary. In attempting
immunohistochemical staining certain problems arise which should be
considered before choosing a fixative, fixation method and antibody
conjugate.
In choosing a fixative it is important to remember that fixation
confers rigidity on tissue mainly by cross-linking proteins. The better the
cross-linking the better the morphological preservation.

It would thus

seem that a fixative that causes a high degree of cross-linking would be
preferable for histological preparations. Extensive cross-linking, however,
39
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impairs antigens both by direct chemical effects and by structural distortion
(Sternberger, 1986), thus a high degree of cross-linking is not preferable in
tissue to be used for immunological studies.
A fixative that preserves immunoreactivity with one type of antibody
may destroy the other epitopes of the same antigen. If one applies regionspecific immunocytochemistry it becomes evident that different epitopes
are distinct chemical individuals that react differently with different
fixatives (Larsson, 1988).

In other words, a fixative may preserve

reactivity of one epitope in a certain antigen, but may completely destroy
reactivity of other epitopes.

Most fixatives bind covalently with amino

groups and leave carboxy groups and tyrosine and histidine unaffected. In
short, immunocytochemical detection of antigens in fixed tissue depends
only on those groups that are not destroyed by the fixative (Sternberger,
1986). Fixation may also induce conformational changes in the antigens,
thus total impairment of immunoreactivity may be extensive even though
the fixative may directly affect only related chemical groups.
Fixation in itself may serve to extract or displace certain antigens.
Many fixatives penetrate tissues quite slowly. If immersion fixation is to
be used tissue blocks should be as small as possible otherwise the buffer
used to dissolve the fixative may reach the tissue first and extract or
displace the antigen before it is fixed (Larsson, 1988). Whenever possible
fixation should be by perfusion rather than immersion.
In immunocytochemistry, use of poorly fixed tissue often yields
spurious results. This is due to nonspecific binding and a high background
generally attributed to Fc receptors or to "endogenous peroxidases." Red
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blood cells and granulocytes possess a true endogenous peroxidase which
becomes stained when exposed to diaminobenzidine and hydrogen peroxide
(Sternberger, 1986). Poorly fixed areas in tissue as well as necrotic areas
exhibit a tendency toward nonspecific staining even in the absence of
primary antibody, and this is also referred to as "endogenous peroxidase"
activity. This activity can be minimized by perfusion of the animal with
physiological solutions followed by perfusion with fixative.

The main

purpose of the perfusion is not, however, elimination of red blood cells but
assurance of better fixation than can be afforded by tissue immersion.
Endogenous peroxidase activity can further be eliminated using various
techniques such as treatment with
(Sternberger, 1986).

methanolic hydrogen peroxide

A logical alternative for avoiding problems with

endogenous peroxidases is to use staining procedures which do not employ
diaminobenzidine or hydrogen peroxide,

such as immunogold

or

immunofluorescence.
When using immunofluorescence one should consider using the
mounting media described for coverslipping slides rather than using
permount since permount has a tendency to fluoresce at various
wavelengths.

Also, this mounting media is preferable to a glycerin

mounting procedure because the mounting media becomes a gel and
provides better support and protection for the tissue, especially when
viewed under high power objectives (100X) which may put pressure on the
coverslip and inadvertently damage the tissue.
Advances in antibody production and purification now make it
possible to produce large quantities of highly specific antibodies. This has
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opened the door to the use of less mild fixatives and many optimal fixatives
for tissue preservation have found application in immunocytochemistry.
Glutaraldehyde, by virtue of its cross-linking qualities, hardens
tissues so much that it prevents its own penetration.

Mixtures of

formaldehyde and glutaraldehyde however, do not encounter this difficulty.
Glutaraldehyde fixation may be followed by osmium tetroxide for further
membrane stabilization, however if used in postembedding staining
electron microscopy, the osmium must be removed by oxidation with
hydrogen peroxide, periodic acid, or permanganate with oxalic acid.
Another

consideration

before

attempting

immunocytochemical

staining is the location of the antigen. Antigens localized in extracellular
spaces, as well as low molecular weight antigens are more prone to
extraction or displacement than large molecular weight antigens (Larsson,
1988).
The tissue generated in this study performed well for light
microscopic immunolabelling techniques, the only inconsistency being in
the labelling of the liquor folliculi. The variation in labelling of the liquor
folliculi of antral follicles may be related to the process of embedding the
tissue. Since the liquor folliculi is a fluid, it, along with the other fluids of
the tissue, is replaced by the embedding medium during the process of
dehydration and infiltration. Thus it would be expected that much of the
contents of these fluids would be extracted during tissue preparation.
Goat anti-mouse IgA was used as the primary antibody on randomly
selected tissue to determine the presence of IgA in the ZP. The results
indicate faint labelling which is due to cross-reactivity between mouse IgA
and hamster IgA.

Cross reactivity between hamster and other species,
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including rodents, is expected to be minimal (John Coe, personal
communication).
The faint labelling seen in controls treated with rabbit anti-goat IgG
is attributable to cross-reactivity. This is expected since anti-goat IgG may
cross-react with the hamster IgG of the ZP.
Labelling problems were encountered when the study shifted to
electron

microscopy.

A

factor

of

utmost

importance

in

all

immunocytochemistry is the binding of secondary antibody to the primary
antibody. Protein A gold exhibits very weak binding when reacted with
goat IgG (Amersham technical bulletin) thus poor results, if any, would be
expected when using GAH-IgG as a primary antibody, as was used in the
light microscopic study.

Protein A gold exhibits strong binding when

reacted with rabbit IgG (Amersham technical bulletin) thus an anti-hamster
antibody raised in rabbit should give desirable results as a primary
antibody followed by treatment with protein A gold.
When using anti-hamster IgG, anti-hamster FP, and anti-hamster
albumin raised in rabbit followed with PAG-15, positive labelling was seen
only on albumin treated sections. This would indicate that the anti-hamster
IgG and anti-hamster FP did not bind to the sections.

Since this tissue

differs from that used in the light microscopic study in two ways, fixative
used and embedding media, the explanation for the lack of labelling of FP
and IgG may lie in these two areas.
As previously described, a particular fixative may provide for
excellent staining of one antigen while completely destroying other
antigens.

A paraformaldehyde/glutaraldehyde mixture was used for

fixation of tissues to be examined by electron microscopy.

In this case

44

glutaraldehyde could be implicated as the undesirable fixative since binding
of the primary antibody to paraformaldehyde fixed tissues did not appear to
be a problem in the light microscopic study. The use of gluteraldehyde,
however, was necessary to obtain morphology suitable for electron
microscopic examination.
The other variable that was changed between the light and electron
microscopic studies was the use of lowicryl K4M and its accompanying
preparation for embedding in place of JB4 + . Preparation for embedding
in JB4+ involved tissue immersion in JB4+ infiltration medium as a
dehydration procedure whereas lowicryl embedding required tissue
dehydration prior to immersion in the lowicryl. Dimethylformamide was
used as the dehydration medium as previously discussed.
In preliminary experiments for light microscopy, DMF was used as
a dehydrating agent prior to embedding in JB4 + .

No morphological

advantage was seen in tissue prepared in this manner, so the DMF was
dropped from the protocol. Immunolabelling of the ZP was observed in
these DMF dehydrated tissues, this would seem to indicate that DMF
dehydration is compatible with the antigens in question and quite probably
is not responsible for the failure to label tissues for electron microscopy.
Lowicryl is generally accepted as the polymer of choice when
working with immunochemistry at the electron microscopic level. One of
the advantages of lowicryl being that it can be used at low temperatures
which protects tissues and presumably antigen binding sites.

However,

some antigens that have been detected using immunogold reagents on
ultrathin frozen sections were undetectable when embedded in lowicryl
K4M (Kerjaschki et al., 1986). No concrete explanation has been given
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for this phenomena but one possible explanation is that the ultraviolet light
used for polymerization of the lowicryl may have adverse effects on some
antigens.
The results of both the light and electron microscopic studies
indicate that intra-ovarian albumin is localized in the ZP and liquor folliculi
of hamster ovarian follicles. Albumin has a negative charge, thus it is not
surprising to find it bound to the ZP since, according to Sellens and
Jenkinson (1975), the ZP might be expected to bind negatively charged
molecules.

Albumin is also described as a carrier molecule which is

responsible for mediating functions of steroid-producing and steroidresponding cells (Krishna and Spanel-Borowski, 1989). Albumin is also
implicated in initiating endocytosis of a ligand with or without
internalization of the albumin itself, as well as being responsible for
removing ligands from target cells. The possibility then exists for albumin
to carry substances to the oocyte and at the same time remove proteins
from the oocyte.
The localization of anti-hamster IgG in the ZP and not in the oocyte
suggests that the ZP is impermeable to hamster IgG. It is not known if IgG
is bound to the ZP or if it is merely trapped within the fibrillogranular
matrix of the ZP.

Since IgG is an initiator of the complement fixation

pathway it would seem imperative to the survival of the oocyte that it not
be allowed to reach the oocyte where it could literally mark the oocyte as a
target for cell lysis and phagocytosis.
Anti-hamster FP also localized in the area of the ZP but not within
the oocyte. This suggests that the ZP of the hamster is impermeable to FP.
The nature of binding of the FP to the ZP is not known and the possibility
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that FP is trapped in the ZP rather than bound to it must be considered. To
reiterate, FP is the hamster homologue to serum amyloid protein and/or Creactive protein from other mammals and has been implicated in the
initiation

of the

complement

fixation pathway

and

in enhanced

phagocytosis. Again, a barrier to prevent this protein from reaching the
oocyte is imperative.
The liquor folliculi is a transudate of blood serum, and as such
contains many of the same proteins. This means that serum proteins must
traverse the endothelial wall of the thecal capillaries and pass either
through or between granulosa cells to reach the ZP and to eventually form
liquor folliculi in the antral cavity of the follicle.
The injection studies conducted with fluorescein conjugated hamster
IgG demonstrate that circulating IgG reaches the level of the ZP in less
than 30 minutes.

These also reveal that the immunoglobulin is located

between granulosa cells, which is in agreement with findings of the indirect
immunolabelling study. Large patches of fluorescence located between the
granulosa cells are believed to be the initial stages of development of the
liquor folliculi and thus depicts the initial formation of the antrum of the
follicle.
Control animals, injected with FITC in physiologic saline, did not
exhibit labelling outside of the blood vessels.

This indicates that the

vessels of the theca are not readily permeable to FITC that has been
conjugated to physiological saline, but are permeable to FITC-conjugated
IgG. This suggests that a mechanism exists for allowing passage of certain
molecules while impeding the passage of others. In the case of IgG this
process

may

be

receptor

mediated

as

previously

described.
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Immunoglobulin G is the only class of immunoglobulin that is known to
cross the placental barrier and this phenomena is believed to be a receptor
mediated event (Goodman, 1987; Steward, 1974). Immunoglobulin G Fc
receptors have been isolated and it is believed that these receptors play a
role in the transport of IgG (Van de Winkel and Anderson, 1991).
Similar studies using fluorescein conjugated serum globulins were
conducted in the rat by Mancini et al. (1963). They describe patches of
fluorescence in the oocyte itself. They concluded that the ZP was at least
partially permeable to serum globulins. The findings of the current study
do not support their results. No fluorescence, beyond that seen in control
animals, was seen in the oocytes.

Thus the suggestion that the ZP is

impermeable to serum IgG is supported.
At this point a brief summary of events seems appropriate. The ZP
and liquor folliculi both label for the presence of IgG, FP, and albumin.
These proteins are derived from serum and become localized in the ZP and
antrum.
Since both IgG and FP are known to initiate the complement fixation
pathway, and all the necessary complement components have been found in
the liquor folliculi, it seems that a system exists which could cause cell
death on a large scale.

This system would also allow for subsequent

phagocytosis of the tissue. This allows for the rather rapid and complete
follicular atresia that is seen in hamsters.
The function of an oocyte is to mature to the stage of ovulation,
become fertilized, and develop into a viable embryo.

If the follicular

oocyte is surrounded by proteins, the primary function of which is
complement fixation, then a mechanism must exist which impedes the
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initiation of the complement cascade. Not all follicles mature to ovulation.
Some become atretic and their cells,
phagocytized.

including the oocyte,

are

This study raises the possibility that atresia is due to an

inability on the part of the oocyte to block the complement cascade in the
follicle.

This is evidenced by the fact that remnants of zona pellucida

atretica seen in the injection study did not exhibit the fluorescence afforded
by the FITC-conjugated hamster IgG unless remnants of the oocyte or
phagoctyes were seen inside the borders of the ZP. However ZP remnants
seen in the indirect labelling study did exhibit labelling. This suggests that
IgG is not circulated to zona pellucida atretica that do not contain antigenic
substances.
It has been suggested by Chamberlin et al. (1989) that some proteins
of the ZP are only coded for by the oocyte genome. The possibility exists
that one or more of these proteins may function to block the initiation of
the complement fixation pathway. In order to do this, these proteins would
themselves have to localize in the ZP. This suggests a possible role for
albumin in the ZP, since, as previously described, albumin may be
responsible for extraction of a ligand from the target cell. The albumin
may be responsible for either the extraction of complement blocking
proteins from the oocyte or sequestering these proteins in the ZP, or
perhaps both.
This study suggests that all ovarian follicles are viewed equally by
the immune system and that only follicles containing oocytes capable of
producing a complement blocking protein will mature to ovulation.
Oocytes of atretic follicles perhaps lack the ability to synthesize the
proteins required to block the complement pathway. This may be brought
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about by chromosomal abnormalities that may have occurred during the
long arrested prophase of meiosis I.
In summary, the ZP of the hamster has been found to impede the
entry of IgG, FP,and albumin into the oocyte, thereby providing a barrier
between the oocyte and the maternal immune system. In addition, the ZP
holds proteins associated with the complement fixation pathway.

Under

the appropriate conditions the complement system is blocked and the
oocyte can proceed to ovulation. The suggestion is made that the oocyte is
responsible for its own survival by producing proteins that block the
complement cascade. Oocytes which are not capable of providing for their
own protection become atretic and are phagocytized.

APPENDICES
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Appendix A Plates And Figures
PLATE I
Figure 1.

Fluorescence micrograph of an ovary harvested at 1000 hours
on day one of the estrous cycle. Treated with GAH-IgG and
FITC-conjugated rabbit anti-goat IgG as a secondary antibody.
X 180.

Figure 2.

Fluorescence micrograph of a hamster ovary harvested at
1400 hours on day one of the estrous cycle. Treated with goat
anti-hamster IgG as a primary antibody and FITC-conjugated
rabbit anti-goat IgG as a secondary antibody.

Note the

fluorescence between the granulosa cells in the large follicle
(right). X 460.
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PLATE II
Figure 3.

Fluorescence micrograph of an ovary harvested at 1400 hours
on day one of the estrous cycle.

Treated with goat anti

hamster IgG as a primary antibody followed by FITCconjugated rabbit anti-goat IgG as a secondary antibody. Note
the slight labelling between the granulosa cells as well as the
labelling of remnants of zona pellucida atretica (upper left). X
900.

Figure 4.

Fluorescence micrograph of an ovary harvested at 1000 hours
on day two of the estrous cycle. Control tissue treated with
FITC-conjugated rabbit anti-goat IgG only. X 900.
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PLATE III
Figure 5.

Light micrograph of an ovarian follicle in an hamster ovary
harvested at 1400 hours on day one of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 4600.

Figure 6.

Light micrograph of an ovarian follicle in an hamster ovary
harvested at 1400 hours on day one of the estrous cycle.
Treated with peroxidase-conjugated rabbit anti-goat IgG only.
X 4600.
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PLATE IV
Figure 7.

Light micrograph of a hamster ovary harvested at 1400 hours
on day one of the estrous cycle.

Treated with goat anti

hamster IgG as a primary antibody followed by peroxidaseconjugated rabbit anti-goat IgG as a secondary antibody. X
4600.

Figure 8.

Light micrograph of a hamster ovary harvested at 1400 hours
on day one of the estrous cycle.

Treated with peroxidase-

conjugated rabbit anti-goat IgG only. X 1800.

v V#
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PLATE V
Figure 9.

Light micrograph of three follicles located in an ovary
harvested at 0200 hours on day two of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. Note the faint labelling in the primary
unilaminar follicle. X 1800.

Figure 10.

Light micrograph of section taken through the same follicles
seen in Fig. 9.

Control tissue treated with peroxidase-

conjugated rabbit anti-goat IgG only. X 1800.
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PLATE VI
Figure 11.

Light micrograph of a primary unilaminar follicle seen in an
ovary harvested at 1000 hours on day two of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 4600.

Figure 12. Light micrograph of a primary unilaminar follicle in an ovary
harvested at 1400 hours on day two of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 4600.
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PLATE VII
Figure 13.

Light micrograph of an ovary harvested at 1000 hours on day
two of the estrous cycle. Treated with Goat anti-hamster IgG
as a primary antibody followed by peroxidase-conjugated
rabbit anti-goat IgG as a secondary antibody. X 1800.

Figure 14.

Fluorescence micrograph of a section through the same
follicles seen in Fig. 13. Treated with goat anti-hamster IgG
as a primary antibody followed by FITC-conjugated rabbit
anti-goat IgG as a secondary antibody. X 1800.
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PLATE VIII
Figure 15.

Light micrograph of an ovary harvested at 1400 hours on day
two of the estrous cycle. Treated with goat anti-hamster IgG
as a primary antibody followed by peroxidase-conjugated
rabbit anti-goat IgG as a secondary antibody. X 900.

Figure 16.

Light micrograph of sections through the same follicles seen in
Fig. 15.

Control tissue treated with peroxidase-conjugated

rabbit anti-goat IgG only. X 900.
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PLATE IX
Figure 17. Light micrograph of an ovary harvested at 1400 hours on day
two of the estrous cycle. Treated with goat anti-mouse IgA as
a primary antibody followed by peroxidase-conjugated rabbit
anti-goat IgG as a secondary antibody. X 900.

Figure 18. Light micrograph of two multilaminar follicles in an ovary
harvested at 1400 hours on day two of the estrous cycle.
Treated with goat anti-mouse IgA as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 1800.
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PLATE X
Figure 19. Light micrograph of a multilaminar follicle in an ovary
harvested at 1000 hours on day three of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 1800.

Figure 20. Light micrograph of two multilaminar follicles seen in an
ovary harvested at 1000 hours on day three of the estrous
cycle.

Treated with goat anti-hamster IgG as a primary

antibody followed by peroxidase-conjugated rabbit anti-goat
IgG as a secondary antibody. X 1800.
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PLATE XI
Figure 21.

Light micrograph of a multilaminar follicle seen in an ovary
harvested at 1400 hours on day three of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 1800.

Figure 22. Light micrograph of an ovary harvested at 1400 hours on day
three of the estrous cycle. Treated with Goat anti-hamster IgG
as a primary antibody followed by peroxidase-conjugated
rabbit anti-goat IgG as a secondary antibody.

Note the

labelling in the small bilaminar follicle (center) as well as the
labelling of the remnants of the zona pellucida atretica.
1800.

X
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PLATE XII
Figure 23.

Fluorescence micrograph of a follicle seen in an ovary
harvested at 1400 hours on day four of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by FITC-conjugated rabbit anti-goat IgG as a
secondary antibody. X 1800.

Figure 24.

Fluorescence micrograph of follicles seen in an ovary
harvested at 1400 hours on day four of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by FITC-conjugated rabbit anti-goat IgG as a
secondary antibody. X 1800.
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PLATE XIII
Figure 25.

Light micrograph of a follicle seen in an ovary harvested at
2200 hours on day four of the estrous cycle.

Treated with

goat anti-mouse IgA as a primary antibody followed by
peroxidase-conjugated rabbit anti-goat IgG as a secondary
antibody. X 1800.

Figure 26.

Light micrograph of a multilaminar follicle seen in an ovary
harvested at 2200 hours on day four of the estrous cycle.
Treated with goat anti-hamster IgG as a primary antibody
followed by peroxidase-conjugated rabbit anti-goat IgG as a
secondary antibody. X 4600.
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PLATE XIV
Figure 27. Light micrograph of a follicle seen in an ovary harvested at
1400 hours on day four of the estrous cycle.

Treated with

rabbit anti-FP as a primary antibody followed by peroxidaseconjugated goat anti-rabbit IgG as a secondary antibody. X
1800.

Figure 28. Light micrograph of a follicle seen in an ovary harvested at
1400 hours on day three of the estrous cycle. Treated with
rabbit anti-albumin as a primary antibody followed by
peroxidase-conjugated goat anti-rabbit IgG as a secondary
antibody. X 1800.
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PLATE XV
Figure 29. Electron micrograph of the ZP of a follicle seen in an ovary
harvested at 1400 hours on day four of the estrous cycle.
Treated with rabbit anti-hamster albumin as a primary
antibody followed by PAG-15. X 17,500.

Figure 30. Electron micrograph of the ZP of a follicle seen in an ovary
harvested at 1400 hours on day four of the estrous cycle.
Control tissue treated with PAG-15 only. X 16,100.
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PLATE XVI
Figure 31. Fluorescence micrograph of a hamster ovary harvested at
1000 hours on day one of the estrous cycle. The animal was
injected i.v. with FITC-conjugated hamster IgG one hour
before euthanasia.

Note spots of fluorescence between

granulosa cells denoting initial formation of liquor folliculi. X
460.

Figure 32. Fluorescence micrograph of a multilaminar follicle seen in an
ovary harvested at 1000 hours on day one of the estrous cycle.
The animal was injected i.v. with FITC-conjugated hamster
IgG one hour before euthanasia.

Note the thin band of

fluorescence at the level of the granulosa cell basement
membrane. X 1800.
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PLATE XVII
Figure 33. Fluorescence micrograph of two follicles seen in a hamster
ovary harvested at 1000 hours on day one of the estrous cycle.
The animal was injected i.v. with FITC-conjugated hamster
IgG one hour before euthanasia.

Note the fluorescence

between granulosa cells in the multilaminar follicle (right) and
in the antrum of the antral follicle (left). X 900.

Figure 34. Fluorescence micrograph of an ovary harvested at 1000 hours
on day one of the estrous cycle. The animal was injected i.v.
with

FITC-conjugated

hamster

IgG

one

hour

before

euthanasia. Note the fluorescence seen in the antrum of the
two antral follicles (center and left) as well as the lack of
fluorescence in the remnants of zona pellucida atretica.
460.

X
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PLATE XVIII
Figure 35. Fluorescence micrograph of a bilaminar follicle seen in an
ovary harvested at 1000 hours on day two of the estrous cycle.
The animal was injected i.v. with FITC-conjugated hamster
IgG one hour before euthanasia. X 1800.

Figure 36. Fluorescence micrograph of a multilaminar follicle seen in an
ovary harvested at 1000 hours on day two of the estrous cycle.
The animal was injected i.v. with FITC-conjugated hamster
IgG one hour before euthanasia. Note areas of fluorescence
between granulosa cells presumably marking initial formation
of liquor folliculi. X 1800.
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PLATE XIX
Figure 37. Fluorescence micrograph of two multilaminar follicles seen in
an ovary harvested at 1000 hours on day two of the estrous
cycle.

The animal was injectd i.v. with FITC-conjugated

hamster IgG one hour before euthanasia. X 900.

Figure 38. Fluorescence micrograph of a hamster ovary harvested at
1000 hours on day two of the estrous cycle. The animal was
injected i.v. with FITC-conjugated hamster IgG one hour
before euthanasia.

Note the lack of fluorescence of the

remnants of zona pellucida atretica (center) as well as in the
ZP of the atretic follicle (right).

Also note spots of

fluorescence on the oocyte coat in the atretic follicle. X 900.
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PLATE XX
Figure 39. Fluorescence micrograph of a multilaminar follicle seen in an
ovary harvested at 1000 hours on day three of the estrous
cycle.

The animal was injected i.v. with FITC-conjugated

hamster IgG 30 minutes before euthanasia. X 1800.

Figure 40. Fluorescence micrograph of a multilaminar follicle seen in an
ovary harvested at 1000 hours of day three of the estrous
cycle.

The animal was injected i.v. with FITC-conjugated

hamster IgG 30 minutes before euthanasia. X 1800.

V
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PLATE XXI
Figure 41. Fluorescence micrograph of an antral follicle as seen in an
ovary harvested at 1000 hours on day three of the estrous
cycle.

The animal was injected i.v. with FITC-conjugated

hamster IgG one hour before euthanasia. X 900.

Figure 42. Fluorescence micrograph of an antral follicle seen in an ovary
harvested at 1000 hours on day three of the estrous cycle.
The animal was injected i.v. with FITC-conjugated hamster
IgG one hour before euthanasia. X 900.
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PLATE XXII
Figure 43. Fluorescence micrograph of three follicles seen in an ovary
harvested at 1000 hours on day four of the estrous cycle. The
animal was injected i.v. with FITC-conjugated hamster IgG
one hour before euthanasia. X 900.

Figure 44. Fluorescence micrograph of three follicles seen in an ovary
harvested at 1000 hours on day three of the estrous cycle.
Control tissue - the animal was injected i.v. with FITC in
physiologic saline one hour before euthanasia. X 900.
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Appendix B Immunological Agents And Their Suppliers

Sigma Chemical Co. St Louis MO
Anti-Goat IgG (Whole Molecule) FITC Conjugate developed
in rabbit
Anti-Rabbit IgG (Whole molecule) TRITC Conjugate developed
in goat
Fluorescein Isothiocyanate

Cappel (Organon-Teknika) Durham NC
IgG fraction Goat Anti-Hamster IgG (Heavy and Light
Chain Specific)
Goat Anti-Mouse IgA (Alpha Chain Specific)
Peroxidase Conjugated IgG fraction Rabbit Anti-Goat IgG
(F(ab')2 Fragment Specific
Peroxidase Conjugated IgG fraction Goat Anti-Rabbit IgG
(F(ab')2 fragment specific
Chromatographically purified Hamster IgG

Janssen (Amersham) Picataway NJ
Protein A Gold 15 nm
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The following three antibodies were a generous gift from Dr. John Coe at
the National Institute of Health, Rocky Mountain Laboratory, Hamilton,
MT:
Rabbit Anti-Hamster IgG nonspecific
Rabbit Anti-Hamster Female Protein
Rabbit Anti-Hamster Albumin
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